WEAVER GREGORY L
Chief Financial Officer
WEAVER GREGORY L has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 3, 2026.
On the most recent filing, WEAVER GREGORY L is listed as Chief Financial Officer at Altimmune, Inc. Inside the rolling window, WEAVER GREGORY L reported 2 open-market purchases totaling $49K in ALT and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 ALT shares on Apr 1, 2026, worth $31K.
Companies traded
Other insiders at ALT
Insider Buying
$49K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WEAVER GREGORY L made?
WEAVER GREGORY L has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does WEAVER GREGORY L trade?
WEAVER GREGORY L has filed SEC Form 4 disclosures for 1 company, including ALT.
When was WEAVER GREGORY L's most recent SEC Form 4 filing?
WEAVER GREGORY L's most recent SEC Form 4 filing on Tracefour is dated Aug 3, 2026.
What is WEAVER GREGORY L's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, WEAVER GREGORY L is listed as Chief Financial Officer.
What is WEAVER GREGORY L's total buy and sell value in the current window?
Inside the rolling retention window, WEAVER GREGORY L bought $49K and sold $0 based on SEC Form 4 filings.
What was WEAVER GREGORY L's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 ALT shares on 2026-04-01, worth $31K, per SEC Form 4 filings.